The goal of this clinical trial is to evaluate if a nursing intervention based on the carbohydrate-insulin model can effectively reduce weight and manage the risk of metabolic syndrome (MetS) in individuals with first-episode psychosis. The main questions it aims to answer are: Will the intervention lead to a clinically significant weight loss (≥5%)? Can the intervention improve metabolic parameters, psychopathological state, physical activity level, and quality of life? Researchers will compare participants receiving the specialized nursing consultations to those receiving routine care to see if the former group experiences greater improvements in weight loss and metabolic risk reduction. Participants will: Attend a series of 8 nursing consultations focused on dietary habits based on the carbohydrate-insulin model and physical activity. Complete assessments at the start, 6 months, and 12 months, including weight, metabolic parameters, and psychological evaluations.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
88
Based on the Carbohydrate-insulin Theory
Hospital Universitario Basurto
Bilbao, Vizcaya, Spain
RECRUITINGWeight
Weight in kilograms
Time frame: From enrollment to the end of treatment at 48 weeks
Metabolic Syndrome
According to the International Diabetes Federation (IDF)
Time frame: From enrollment to the end of treatment at 48 weeks
Psychopathology
measured using PANSS scale
Time frame: From enrollment to the end of treatment at 48 weeks
Depressive symptoms
measured by Hamilton Depression Rating Scale
Time frame: From enrollment to the end of treatment at 48 weeks
Qualit of Life
EuroQoL 5D scale will be used
Time frame: From enrollment to the end of treatment at 48 weeks
Reported phisical activity
International Physical Activity Questionnaire (IPAQ)
Time frame: From enrollment to the end of treatment at 48 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.